Evaluation of Sagittal Abdominal Diameter as a Predictor of the Skin to Epidural Space Distance in Obese Patients
Launched by AIN SHAMS UNIVERSITY · Sep 17, 2019
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the size of a person's abdomen (measured from front to back, called the sagittal abdominal diameter or SAD) can help predict the distance from the skin to the epidural space in obese patients. This is important because accurate measurements can make epidural anesthesia (a type of pain relief used during surgery) safer and more effective. The researchers want to see if using SAD is more accurate than the Body Mass Index (BMI), which is a common way to assess body weight relative to height.
To participate in this study, individuals must be 18 years or older, have a BMI between 30 and 39.9, and be scheduled for elective surgery on their lower legs that will use epidural anesthesia. Unfortunately, pregnant women and those who cannot receive an epidural due to medical reasons cannot join the trial. Participants will likely have some measurements taken and may help researchers learn more about how to improve anesthesia care for people with obesity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • BMI 30 to 39.9
- • Either sex
- • Elective surgery on lower extremities performed under epidural anesthesia
- Exclusion Criteria:
- • Pregnant women
- • Contraindications to epidural block
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials